226 related articles for article (PubMed ID: 34105271)
1. A Microfluidic Multisize Spheroid Array for Multiparametric Screening of Anticancer Drugs and Blood-Brain Barrier Transport Properties.
Eilenberger C; Rothbauer M; Selinger F; Gerhartl A; Jordan C; Harasek M; Schädl B; Grillari J; Weghuber J; Neuhaus W; Küpcü S; Ertl P
Adv Sci (Weinh); 2021 Jun; 8(11):e2004856. PubMed ID: 34105271
[TBL] [Abstract][Full Text] [Related]
2. AlgiMatrix™ based 3D cell culture system as an in-vitro tumor model for anticancer studies.
Godugu C; Patel AR; Desai U; Andey T; Sams A; Singh M
PLoS One; 2013; 8(1):e53708. PubMed ID: 23349734
[TBL] [Abstract][Full Text] [Related]
3. Multiparametric Analysis of Oncology Drug Screening with Aqueous Two-Phase Tumor Spheroids.
Shahi Thakuri P; Ham SL; Luker GD; Tavana H
Mol Pharm; 2016 Nov; 13(11):3724-3735. PubMed ID: 27653969
[TBL] [Abstract][Full Text] [Related]
4. Droplet-based microfluidic system for multicellular tumor spheroid formation and anticancer drug testing.
Yu L; Chen MC; Cheung KC
Lab Chip; 2010 Sep; 10(18):2424-32. PubMed ID: 20694216
[TBL] [Abstract][Full Text] [Related]
5. Development, Characterization and Potential Applications of a Multicellular Spheroidal Human Blood-Brain Barrier Model Integrating Three Conditionally Immortalized Cell Lines.
Kitamura K; Umehara K; Ito R; Yamaura Y; Komori T; Morio H; Akita H; Furihata T
Biol Pharm Bull; 2021 Jul; 44(7):984-991. PubMed ID: 33896887
[TBL] [Abstract][Full Text] [Related]
6. Studies of anticancer drug cytotoxicity based on long-term HepG2 spheroid culture in a microfluidic system.
Zuchowska A; Kwapiszewska K; Chudy M; Dybko A; Brzozka Z
Electrophoresis; 2017 Apr; 38(8):1206-1216. PubMed ID: 28090668
[TBL] [Abstract][Full Text] [Related]
7. Transport of ultrasmall gold nanoparticles (2 nm) across the blood-brain barrier in a six-cell brain spheroid model.
Sokolova V; Mekky G; van der Meer SB; Seeds MC; Atala AJ; Epple M
Sci Rep; 2020 Oct; 10(1):18033. PubMed ID: 33093563
[TBL] [Abstract][Full Text] [Related]
8. Preclinical evaluation of binimetinib (MEK162) delivered via polymeric nanocarriers in combination with radiation and temozolomide in glioma.
Bikhezar F; de Kruijff RM; van der Meer AJGM; Torrelo Villa G; van der Pol SMA; Becerril Aragon G; Gasol Garcia A; Narayan RS; de Vries HE; Slotman BJ; Denkova AG; Sminia P
J Neurooncol; 2020 Jan; 146(2):239-246. PubMed ID: 31875307
[TBL] [Abstract][Full Text] [Related]
9. Microfluidic blood-brain barrier model provides in vivo-like barrier properties for drug permeability screening.
Wang YI; Abaci HE; Shuler ML
Biotechnol Bioeng; 2017 Jan; 114(1):184-194. PubMed ID: 27399645
[TBL] [Abstract][Full Text] [Related]
10. Generation of uniform-sized multicellular tumor spheroids using hydrogel microwells for advanced drug screening.
Lee JM; Park DY; Yang L; Kim EJ; Ahrberg CD; Lee KB; Chung BG
Sci Rep; 2018 Nov; 8(1):17145. PubMed ID: 30464248
[TBL] [Abstract][Full Text] [Related]
11. A perfused human blood-brain barrier on-a-chip for high-throughput assessment of barrier function and antibody transport.
Wevers NR; Kasi DG; Gray T; Wilschut KJ; Smith B; van Vught R; Shimizu F; Sano Y; Kanda T; Marsh G; Trietsch SJ; Vulto P; Lanz HL; Obermeier B
Fluids Barriers CNS; 2018 Aug; 15(1):23. PubMed ID: 30165870
[TBL] [Abstract][Full Text] [Related]
12. High-throughput microfluidics for evaluating microbubble enhanced delivery of cancer therapeutics in spheroid cultures.
Bourn MD; Batchelor DVB; Ingram N; McLaughlan JR; Coletta PL; Evans SD; Peyman SA
J Control Release; 2020 Oct; 326():13-24. PubMed ID: 32562855
[TBL] [Abstract][Full Text] [Related]
13. Optimizing the Design of Blood-Brain Barrier-Penetrating Polymer-Lipid-Hybrid Nanoparticles for Delivering Anticancer Drugs to Glioblastoma.
Ahmed T; Liu FF; He C; Abbasi AZ; Cai P; Rauth AM; Henderson JT; Wu XY
Pharm Res; 2021 Nov; 38(11):1897-1914. PubMed ID: 34655006
[TBL] [Abstract][Full Text] [Related]
14. Ultrasmall gold nanoparticles (2 nm) can penetrate and enter cell nuclei in an in vitro 3D brain spheroid model.
Sokolova V; Nzou G; van der Meer SB; Ruks T; Heggen M; Loza K; Hagemann N; Murke F; Giebel B; Hermann DM; Atala AJ; Epple M
Acta Biomater; 2020 Jul; 111():349-362. PubMed ID: 32413579
[TBL] [Abstract][Full Text] [Related]
15. Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents.
Cho CF; Wolfe JM; Fadzen CM; Calligaris D; Hornburg K; Chiocca EA; Agar NYR; Pentelute BL; Lawler SE
Nat Commun; 2017 Jun; 8():15623. PubMed ID: 28585535
[TBL] [Abstract][Full Text] [Related]
16. Recent Advances in Multicellular Tumor Spheroid Generation for Drug Screening.
Lee KH; Kim TH
Biosensors (Basel); 2021 Nov; 11(11):. PubMed ID: 34821661
[TBL] [Abstract][Full Text] [Related]
17. Drug testing and flow cytometry analysis on a large number of uniform sized tumor spheroids using a microfluidic device.
Patra B; Peng CC; Liao WH; Lee CH; Tung YC
Sci Rep; 2016 Feb; 6():21061. PubMed ID: 26877244
[TBL] [Abstract][Full Text] [Related]
18. Detachably assembled microfluidic device for perfusion culture and post-culture analysis of a spheroid array.
Sakai Y; Hattori K; Yanagawa F; Sugiura S; Kanamori T; Nakazawa K
Biotechnol J; 2014 Jul; 9(7):971-9. PubMed ID: 24802801
[TBL] [Abstract][Full Text] [Related]
19. A Microfluidic Platform for Evaluating the Internalization of Liposome Drug Carriers in Tumor Spheroids.
Yakavets I; Ayachit M; Kheiri S; Chen Z; Rakhshani F; McWhirter S; Young EWK; Walker GC; Kumacheva E
ACS Appl Mater Interfaces; 2024 Feb; 16(8):9690-9701. PubMed ID: 38357740
[TBL] [Abstract][Full Text] [Related]
20. High-Throughput Screening of Anti-cancer Drugs Using a Microfluidic Spheroid Culture Device with a Concentration Gradient Generator.
Lee Y; Chen Z; Lim W; Cho H; Park S
Curr Protoc; 2022 Sep; 2(9):e529. PubMed ID: 36066205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
